2022
Generalizing Trial Evidence to Target Populations in Non-Nested Designs: Applications to AIDS Clinical Trials
Li F, Buchanan AL, Cole SR. Generalizing Trial Evidence to Target Populations in Non-Nested Designs: Applications to AIDS Clinical Trials. Journal Of The Royal Statistical Society Series C (Applied Statistics) 2022, 71: 669-697. PMID: 35968541, PMCID: PMC9367209, DOI: 10.1111/rssc.12550.Peer-Reviewed Original ResearchAIDS Clinical Trials GroupTarget populationClinical Trials GroupComparative effectiveness evidenceTreatment effectsRandomized trialsTrial evidenceClinical trialsTrial groupHIV interventionsACTG trialsTrial participantsTrial designPropensity scoreEffectiveness evidenceTrialsAIDS clinical trialsSpecified populationPopulationAverage treatment effectMost casesHIVEvidenceRegression
2021
A note on semiparametric efficient generalization of causal effects from randomized trials to target populations
Li F, Hong H, Stuart E. A note on semiparametric efficient generalization of causal effects from randomized trials to target populations. Communication In Statistics- Theory And Methods 2021, 52: 5767-5798. PMID: 37484707, PMCID: PMC10361688, DOI: 10.1080/03610926.2021.2020291.Peer-Reviewed Original Research
2020
Propensity score weighting for covariate adjustment in randomized clinical trials
Zeng S, Li F, Wang R, Li F. Propensity score weighting for covariate adjustment in randomized clinical trials. Statistics In Medicine 2020, 40: 842-858. PMID: 33174296, DOI: 10.1002/sim.8805.Peer-Reviewed Original Research